Healthcare & Life Sciences
FluGen
United Stateswww.flugen.com/
FluGen is a Healthcare & Life Sciences startup based in the United States, most recent round Series A, 4 tracked investors.
Activeseries-a
series-a
Stage
4
Investors
About FluGen
FluGen is a company headquartered in the United States. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 4 investors associated with the company.
FluGen develops intranasal vaccines based on its M2SR platform to provide broad, effective protection against influenza and other respiratory diseases by stimulating mucosal, humoral, and cellular immunity.
Explore FluGen's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.